Showing results 1 to 4 of 4
A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer Ko, Soyeon; Jung, Kyung Hee; Yoon, Young -Chan; Han, Beom Seok; Park, Min Seok; Lee, Yun Ji; Kim, Sang Eun; et al, AMERICAN JOURNAL OF CANCER RESEARCH, v.12, no.9, pp.4326 - 4342, 2022-10 |
HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer Park, Jung Hee; Jung, Kyung Hee; Kim, Soo Jung; Yoon, Young-Chan; Yan, Hong Hua; Fang, Zhenghuan; Lee, Ji Eun; et al, CANCER LETTERS, v.444, pp.94 - 104, 2019-01 |
HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer Rumman, Marufa; Jung, Kyung Hee; Fang, Zhenghuan; Yan, Hong Hua; Son, Mi Kwon; Kim, Soo Jung; Kim, Juyoung; et al, ONCOTARGET, v.7, no.47, pp.78029 - 78047, 2016-11 |
HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation![]() Kim, Soo Jung; Jung, Kyung Hee; Yan, Hong Hua; Son, Mi Kwon; Fang, Z; Ryu, Ye-Lim; Lee, Hyunseung; et al, ONCOTARGET, v.6, no.3, pp.1507 - 1518, 2015-01 |
Discover